Pregnancy is one of the main risk factors for the development of venous thromboembolic disease (VTED). The objective of this work was to analyze the diagnostic and therapeutic elements of venous thrombosis in pregnant women followed at the Centre médical Diamant in Lubumbashi (CMDL). This is a descriptive cross-sectional study over a period of 27 months at CMDL in DR Congo, including all pregnant women followed for venous thrombosis during the study period. Data analysis was done by SPSS 22.0 software. The prevalence of VTED was 5.2% with a mean age of 27 ± 3 years (Extreme: 21 to 42 years). The telltale signs were dominated by asymmetric swelling of the lower limb (27.3%) and the main location was femoro-popliteal (63.6%). Superficial venous thrombosis was predominant with 54.5%. The diagnosis of VTE was supported by measurement of D-dimer in 100% of cases, confirmed by Doppler ultrasound in 81.8% of cases. Associated factors were non-O blood group (45.5%), history of miscarriages (27.3%), family history (18.2%), age over 35 years (18.2%), multiparity (27.3%) and gestational diabetes (18.2%). The treatment combined low molecular weight heparin in 72.7%. The mean duration of treatment was 28 days (range: 18-42 days). The outcome was favorable in 63.6% of cases. Venous thrombosis in pregnancy remains a major challenge in our environment because the risk factors and specific determinants are not known, there is no preventive or curative protocol adapted to our working conditions. Further, more in-depth studies are needed to optimize and rationalize care.
| Published in | Journal of Gynecology and Obstetrics (Volume 10, Issue 4) |
| DOI | 10.11648/j.jgo.20221004.18 |
| Page(s) | 211-216 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Pregnancy, Venous Thrombosis, DR Congo
| [1] | Le Gal G, Kercret G, Ben Yahmed K et al. Diagnostic value of single complete compression ultrasonography in pregnant and postpartum women with suspected deep vein thrombosis: prospective study. BMJ 2012; 344: e2635. |
| [2] | Konin C., Adoh M., Kramoh E., Aevouelie Kouassi F., Anzouan-Kacou B., N’guetta R., Harding D. – Les thromboses veineuses profondes des membres inférieurs en milieu tropical: aspects épidémiologiques et facteurs étiologiques. Médecine d’Afrique Noire 2004; 51, 8/9: 469-473. |
| [3] | Ondze-Kafata L. I., Kouala Landa C., Traore Kissima A., Loumouamou M., Bani M., AmounyaZobo S. et al – La thrombose veineuse des membres inférieurs à brazzaville: à propos de 44 cas. Cardiologie Tropicale 2012; 135. |
| [4] | Lonjaret L, Lairez O, Minville V, Bayoumeu F, Fourcade O, Mercier FJ. Embolie pulmonaire et grossesse. Société Française d’Anesthésie et de Réanimation. 2013 Mai 22; 32 (2013): 257-266. |
| [5] | Chauleur C, Gris JC, Seffert P, Mismetti P. Actualités sur les facteurs de risque et la prévention des complications thrombotiques de la grossesse. Gynecol Obstét Ferti. 2012 Avr 17; 40 (2012): 301-307. |
| [6] | Chauleur C, Raia T, Gris JC. Thromboprophylaxie pendant la grossesse et le post-partum. La presse Médicale. Sept 2013 12; 42 (9): 1251-1258. |
| [7] | Institut Pasteur. Conférence de consensus – Thrombophilie et grossesse – Prévention des risques thrombotiques maternels et placentaires – Texte de recommandations (version longue). ANAES; 2003 Mar 14. |
| [8] | Société Française des médecins Anesthésistes-Réanimateurs. Prévention de la maladie thromboembolique veineuse périopératoire obstétricale – Recommandations pour la pratique clinique – Texte court. 2005: 30-33. |
| [9] | Chauleur C, et al. Use of the Delphi method to facilitate antithrombotics prescription during pregnancy. Thromb Res. 2010 Jan 17. 43. |
| [10] | Tran HA, Gibbs H, Merriman E, Curnow JL, Young L, Bennett A, Tan CW, Chunilal SD, Ward CM, Baker R, Nandurkar H. Tran HA, et al. New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism. Med J Aust. 2019 Mar; 210 (5): 227-235. |
| [11] | Kane E, et al. A population-based study of venous thrombosis in pregnancy in Scotland 1890-2005. Eur J Obstet Gyn R B. 2013 Mar 29; 169 (2013): 223-229. |
| [12] | Nougier C et Marijon A Caractéristiques immuno-analytiques des D-dimères. Immuno-analyse et Biologie médicale spécialisée 2012; 27: 85-88. |
| [13] | Jacobsen A, Skjeldestad F, Sandset P. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium – a registred-based case-control study. Am J Obstet Gynecol. 2008; 198 (233): 1-7. |
| [14] | Simpson E, Lawrenson R, Nightingale A, Farmer R. Venous thromboemeolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. Bjog. 2001; 108: 56-60. |
| [15] | Benhamou D. Maladie thromboembolique veineuse et grossesse. [Extrait des Mises à jour en Gynécologie et Obstétrique]. Collège National des gynécologues et obstétriciens français. 2010 Dec 10. 169-183. |
| [16] | Singer AJ, Zheng H, Francis S, Fermann GJ, Chang AM, Parry BA, Giordano N, Kabrhel C. Singer AJ, et al. D-dimer levels in VTE patients with distal and proximal clots. Am J Emerg Med. 2019 Jan; 37 (1): 33-37. |
| [17] | Gherman R, Goodwin T, Leung B, Byrne J, Hethumumi R, Montoro M. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol. 1999; 94 (5): 730. 45. |
| [18] | Witlin A, Mattar F, Saade G, Van Hook J, Sibai B. Presentation of venous thromboembolism during pregnancy. Am J Obstet Gynecol. 1999; 181: 1118-21. |
| [19] | James A, Jamison M, Brancazio L, Myers E. Venous thromboembolism during pregnancy and the postpartum period: Incidence, risk factors, and mortality [abstract]. Am J Obstet Gynecol. 2006 Apr 24; 194 (5): 1311 – 1315. |
| [20] | Buthod D, Malloizel J, Monreal M, Bura-Rivière A. Maladie thrombo-embolique veineuse chez la femme enceinte et en post-partum: résultats du registre RIETE. Journal des maladies vasculaires. 2010 Sept; 35 (5): 309-310. |
| [21] | Ginsberg JS, Bates SM. Management of venous thromboembolism during pregnancy. J Thromb Haemost. 2003; 1: 1435–42. |
| [22] | Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 3147-97. |
| [23] | Bates SM, Greer IA, Middeldorp S et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e691S-e736S. |
| [24] | The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). European Heart Journal 2011 Nov, 32: 3147-3197. (Pdf). |
| [25] | Chan WS, Lee A, Spencer FA et al. Predicting deep venous thrombosis in pregnancy: out in “LEFt” field? Ann Intern Med 2009; 151: 85-92. |
| [26] | Thromboembolie veineuse et traitement antithrombotique pendant la grossesse. N° 308, JUNE JOGC JUIN 2014. |
APA Style
Mubinda Kiopin Patrick, Augustin Kibonge Mukakala, Iteke Fefe Rivain, Shaddy Mahfoud, Muanda Panzu Patrick, et al. (2022). Venous Trhomboembolic Diseases in Gestants Followed at the Centre Médical Diamant in Lubumbashi: Analysis of Diagnosis and Therapeutic Elements. Journal of Gynecology and Obstetrics, 10(4), 211-216. https://doi.org/10.11648/j.jgo.20221004.18
ACS Style
Mubinda Kiopin Patrick; Augustin Kibonge Mukakala; Iteke Fefe Rivain; Shaddy Mahfoud; Muanda Panzu Patrick, et al. Venous Trhomboembolic Diseases in Gestants Followed at the Centre Médical Diamant in Lubumbashi: Analysis of Diagnosis and Therapeutic Elements. J. Gynecol. Obstet. 2022, 10(4), 211-216. doi: 10.11648/j.jgo.20221004.18
AMA Style
Mubinda Kiopin Patrick, Augustin Kibonge Mukakala, Iteke Fefe Rivain, Shaddy Mahfoud, Muanda Panzu Patrick, et al. Venous Trhomboembolic Diseases in Gestants Followed at the Centre Médical Diamant in Lubumbashi: Analysis of Diagnosis and Therapeutic Elements. J Gynecol Obstet. 2022;10(4):211-216. doi: 10.11648/j.jgo.20221004.18
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.jgo.20221004.18,
author = {Mubinda Kiopin Patrick and Augustin Kibonge Mukakala and Iteke Fefe Rivain and Shaddy Mahfoud and Muanda Panzu Patrick and Mwape Besa Baltfazar and Prosper Kalenga Muenze},
title = {Venous Trhomboembolic Diseases in Gestants Followed at the Centre Médical Diamant in Lubumbashi: Analysis of Diagnosis and Therapeutic Elements},
journal = {Journal of Gynecology and Obstetrics},
volume = {10},
number = {4},
pages = {211-216},
doi = {10.11648/j.jgo.20221004.18},
url = {https://doi.org/10.11648/j.jgo.20221004.18},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jgo.20221004.18},
abstract = {Pregnancy is one of the main risk factors for the development of venous thromboembolic disease (VTED). The objective of this work was to analyze the diagnostic and therapeutic elements of venous thrombosis in pregnant women followed at the Centre médical Diamant in Lubumbashi (CMDL). This is a descriptive cross-sectional study over a period of 27 months at CMDL in DR Congo, including all pregnant women followed for venous thrombosis during the study period. Data analysis was done by SPSS 22.0 software. The prevalence of VTED was 5.2% with a mean age of 27 ± 3 years (Extreme: 21 to 42 years). The telltale signs were dominated by asymmetric swelling of the lower limb (27.3%) and the main location was femoro-popliteal (63.6%). Superficial venous thrombosis was predominant with 54.5%. The diagnosis of VTE was supported by measurement of D-dimer in 100% of cases, confirmed by Doppler ultrasound in 81.8% of cases. Associated factors were non-O blood group (45.5%), history of miscarriages (27.3%), family history (18.2%), age over 35 years (18.2%), multiparity (27.3%) and gestational diabetes (18.2%). The treatment combined low molecular weight heparin in 72.7%. The mean duration of treatment was 28 days (range: 18-42 days). The outcome was favorable in 63.6% of cases. Venous thrombosis in pregnancy remains a major challenge in our environment because the risk factors and specific determinants are not known, there is no preventive or curative protocol adapted to our working conditions. Further, more in-depth studies are needed to optimize and rationalize care.},
year = {2022}
}
TY - JOUR T1 - Venous Trhomboembolic Diseases in Gestants Followed at the Centre Médical Diamant in Lubumbashi: Analysis of Diagnosis and Therapeutic Elements AU - Mubinda Kiopin Patrick AU - Augustin Kibonge Mukakala AU - Iteke Fefe Rivain AU - Shaddy Mahfoud AU - Muanda Panzu Patrick AU - Mwape Besa Baltfazar AU - Prosper Kalenga Muenze Y1 - 2022/08/24 PY - 2022 N1 - https://doi.org/10.11648/j.jgo.20221004.18 DO - 10.11648/j.jgo.20221004.18 T2 - Journal of Gynecology and Obstetrics JF - Journal of Gynecology and Obstetrics JO - Journal of Gynecology and Obstetrics SP - 211 EP - 216 PB - Science Publishing Group SN - 2376-7820 UR - https://doi.org/10.11648/j.jgo.20221004.18 AB - Pregnancy is one of the main risk factors for the development of venous thromboembolic disease (VTED). The objective of this work was to analyze the diagnostic and therapeutic elements of venous thrombosis in pregnant women followed at the Centre médical Diamant in Lubumbashi (CMDL). This is a descriptive cross-sectional study over a period of 27 months at CMDL in DR Congo, including all pregnant women followed for venous thrombosis during the study period. Data analysis was done by SPSS 22.0 software. The prevalence of VTED was 5.2% with a mean age of 27 ± 3 years (Extreme: 21 to 42 years). The telltale signs were dominated by asymmetric swelling of the lower limb (27.3%) and the main location was femoro-popliteal (63.6%). Superficial venous thrombosis was predominant with 54.5%. The diagnosis of VTE was supported by measurement of D-dimer in 100% of cases, confirmed by Doppler ultrasound in 81.8% of cases. Associated factors were non-O blood group (45.5%), history of miscarriages (27.3%), family history (18.2%), age over 35 years (18.2%), multiparity (27.3%) and gestational diabetes (18.2%). The treatment combined low molecular weight heparin in 72.7%. The mean duration of treatment was 28 days (range: 18-42 days). The outcome was favorable in 63.6% of cases. Venous thrombosis in pregnancy remains a major challenge in our environment because the risk factors and specific determinants are not known, there is no preventive or curative protocol adapted to our working conditions. Further, more in-depth studies are needed to optimize and rationalize care. VL - 10 IS - 4 ER -
Information
Email: